Home » Topics » Regulatory

Regulatory
RSS

Activase cleared by FDA for ischemic stroke

June 14, 1996

No Comments

Colchicine/hydroxychloroquine therapy of AD

June 14, 1996

No Comments

Lithium/nimodipine combination as bipolar I manic disorder treatment

June 14, 1996

No Comments

Xalatan approved for U.S. market

June 14, 1996

No Comments

Actimmune metastatic renal cell carcinoma development terminated

June 14, 1996

No Comments

Augmentin's new dosing/formulation cleared by FDA

June 14, 1996

No Comments

Single-dose hepatitis A vaccine available

June 7, 1996

No Comments

Tranilast: An angiotensin II antagonist

June 7, 1996

No Comments

First chronotherapeutic agent for hypertension and angina now avaliable in U.S.

June 7, 1996

No Comments

Elan acquires rights to diazepam gel formulation

June 7, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

Activase cleared by FDA for ischemic stroke

Colchicine/hydroxychloroquine therapy of AD

Lithium/nimodipine combination as bipolar I manic disorder treatment

Xalatan approved for U.S. market

Actimmune metastatic renal cell carcinoma development terminated

Augmentin's new dosing/formulation cleared by FDA

Single-dose hepatitis A vaccine available

Tranilast: An angiotensin II antagonist

First chronotherapeutic agent for hypertension and angina now avaliable in U.S.

Elan acquires rights to diazepam gel formulation

Today's news in brief

Today's news in brief

Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly

J&J’s Ottava robotic system approved for US pivotal trial

GLP-1s push into MASH as semaglutide 2.4 mg hits endpoints

Regulatory RSS

Regulatory
RSS